BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 23192317)

  • 1. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T; Clarke PB
    Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.
    Wright JM; Dobosiewicz MR; Clarke PB
    Psychopharmacology (Berl); 2013 Feb; 225(4):853-68. PubMed ID: 23052567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
    Brudzynski SM; Komadoski M; St Pierre J
    Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous antagonism of dopamine D1/D2/D3 receptor in the NAc reduces 50-kHz ultrasonic calls in response to rhythmic tactile stroking.
    Shimoju R; Shibata H
    Behav Brain Res; 2021 May; 405():113211. PubMed ID: 33652069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in effort-related decision-making induced by stimulation of dopamine D
    Bryce CA; Floresco SB
    Psychopharmacology (Berl); 2019 Sep; 236(9):2699-2712. PubMed ID: 30972447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent Acute and Enduring Changes in 50-kHz Ultrasonic Vocalizations in Rats Repeatedly Treated With Amphetamine and Dopaminergic Antagonists: New Insights on the Role of Dopamine in Calling Behavior.
    Serra M; Costa G; Onaivi E; Simola N
    Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38174899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats.
    Fraioli S; Cioli I; Nencini P
    Behav Brain Res; 1997 Dec; 89(1-2):199-215. PubMed ID: 9475627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreally-administered dopamine D2-like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews.
    Ward AH; Siegwart JT; Frost MR; Norton TT
    Vis Neurosci; 2017 Jan; 34():E003. PubMed ID: 28304244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
    Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
    Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
    Caine SB; Negus SS; Mello NK; Patel S; Bristow L; Kulagowski J; Vallone D; Saiardi A; Borrelli E
    J Neurosci; 2002 Apr; 22(7):2977-88. PubMed ID: 11923462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.
    Larkin JD; Jenni NL; Floresco SB
    Psychopharmacology (Berl); 2016 Jan; 233(1):121-36. PubMed ID: 26432096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.